NO20065889L - 3-`4-{6-substituert alkanoyl)pyridin-3-yf}-3-fenyl!-5-(1 H-1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler. - Google Patents
3-`4-{6-substituert alkanoyl)pyridin-3-yf}-3-fenyl!-5-(1 H-1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler.Info
- Publication number
- NO20065889L NO20065889L NO20065889A NO20065889A NO20065889L NO 20065889 L NO20065889 L NO 20065889L NO 20065889 A NO20065889 A NO 20065889A NO 20065889 A NO20065889 A NO 20065889A NO 20065889 L NO20065889 L NO 20065889L
- Authority
- NO
- Norway
- Prior art keywords
- oner
- oxazolidin
- triazol
- ylmethyl
- pyridin
- Prior art date
Links
- -1 1H-1,2,3-triazol-1-ylmethyl Chemical group 0.000 title 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 title 1
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 125000001589 carboacyl group Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0411593A GB0411593D0 (en) | 2004-05-25 | 2004-05-25 | Chemical compounds |
| GB0500054A GB0500054D0 (en) | 2005-01-05 | 2005-01-05 | Chemical compounds |
| PCT/GB2005/002051 WO2005116022A1 (en) | 2004-05-25 | 2005-05-24 | 3- `4- {6-substituted alkanoyl) pyridin-3-yl} -3-phenyl! -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20065889L true NO20065889L (no) | 2007-02-20 |
Family
ID=34968778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20065889A NO20065889L (no) | 2004-05-25 | 2006-12-19 | 3-`4-{6-substituert alkanoyl)pyridin-3-yf}-3-fenyl!-5-(1 H-1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20080021012A1 (https=) |
| EP (1) | EP1753754A1 (https=) |
| JP (1) | JP2008500317A (https=) |
| AU (1) | AU2005247668A1 (https=) |
| BR (1) | BRPI0511526A (https=) |
| CA (1) | CA2566963A1 (https=) |
| IL (1) | IL179349A0 (https=) |
| MX (1) | MXPA06013537A (https=) |
| NO (1) | NO20065889L (https=) |
| WO (1) | WO2005116022A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100854211B1 (ko) * | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
| WO2010042887A2 (en) * | 2008-10-10 | 2010-04-15 | Trius Therapeutics | Methods for preparing oxazolidinones and compositions containing them |
| KR101918678B1 (ko) | 2009-02-03 | 2018-11-14 | 머크 샤프 앤드 돔 코포레이션 | Ｒ)-3-(4-(2-(2-메틸테트라졸-5-일)피리딘-5-일)-3-플루오로페닐)-5-히드록시메틸 옥사졸리딘-2-온 디히드로겐 포스페이트의 결정형 |
| US8580767B2 (en) * | 2009-05-28 | 2013-11-12 | Trius Therapeutics, Inc. | Oxazolidinone containing dimer compounds, compositions and methods to make and use |
| KR101561964B1 (ko) | 2013-11-15 | 2015-10-20 | 한국과학기술연구원 | 옥사졸리디논 화합물 및 이를 포함하는 c형 간염 예방 또는 치료용 약학 조성물 |
| EP3795563B1 (en) | 2016-03-31 | 2024-07-17 | Oncternal Therapeutics, Inc. | Indoline analogs and uses thereof |
| WO2021258013A1 (en) | 2020-06-18 | 2021-12-23 | Akagera Medicines, Inc. | Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0009803D0 (en) * | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
| BR0111280A (pt) * | 2000-06-05 | 2003-06-10 | Dong A Pharm Co Ltd | Novos derivados de oxazolidinona e um processo para a preparação dos mesmos |
| JP2005524661A (ja) * | 2002-02-28 | 2005-08-18 | アストラゼネカ アクチボラグ | ３−シクリル−５−（窒素含有５員環）メチル−オキサゾリジノン誘導体と抗菌剤としてのその使用 |
-
2005
- 2005-05-24 EP EP05746537A patent/EP1753754A1/en not_active Withdrawn
- 2005-05-24 CA CA002566963A patent/CA2566963A1/en not_active Abandoned
- 2005-05-24 BR BRPI0511526-4A patent/BRPI0511526A/pt not_active Application Discontinuation
- 2005-05-24 AU AU2005247668A patent/AU2005247668A1/en not_active Abandoned
- 2005-05-24 JP JP2007514087A patent/JP2008500317A/ja active Pending
- 2005-05-24 WO PCT/GB2005/002051 patent/WO2005116022A1/en not_active Ceased
- 2005-05-24 US US11/569,408 patent/US20080021012A1/en not_active Abandoned
- 2005-05-24 MX MXPA06013537A patent/MXPA06013537A/es not_active Application Discontinuation
-
2006
- 2006-11-16 IL IL179349A patent/IL179349A0/en unknown
- 2006-12-19 NO NO20065889A patent/NO20065889L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0511526A (pt) | 2007-12-26 |
| MXPA06013537A (es) | 2007-01-26 |
| US20080021012A1 (en) | 2008-01-24 |
| WO2005116022A1 (en) | 2005-12-08 |
| EP1753754A1 (en) | 2007-02-21 |
| IL179349A0 (en) | 2007-03-08 |
| CA2566963A1 (en) | 2005-12-08 |
| JP2008500317A (ja) | 2008-01-10 |
| AU2005247668A1 (en) | 2005-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20062704L (no) | Azabicykliske heterocykler som cannabinoide reseptormodulatorer | |
| NO971471L (no) | Nye karboksamider med fungicid aktivitet | |
| NO20061657L (no) | Pyrolderivater med antibakteriell aktivitet | |
| NO20062689L (no) | Azabisykliske heterosykler som modulatorer for kannabinoidreseptorer | |
| IL189017A0 (en) | 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-effective agents | |
| NO20064201L (no) | Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling | |
| NO20083207L (no) | Inhibitorer av IAP | |
| NO20062691L (no) | Azabicykliske heterocykler som cannabinoide reseptormodulatorer | |
| NO20074703L (no) | Antibakterielle piperidinderivater | |
| NO20013680L (no) | Ketolidantibiotika | |
| DK2173749T3 (da) | 2-oxo-2-(2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl)-acetamidderivater og beslægtede forbindelser som antisvampemidler | |
| NO20076357L (no) | Azabicykliske heterocykler som cannabinoid reseptor modulatorer | |
| TW200740434A (en) | A prophylactic and/or therapeutic agent for for sleep disorders | |
| NO20035791L (no) | Nye derivater av oksazolidinoner som antibakterielle midler | |
| GEP20084437B (en) | Novel lincomycin derivatives possessing antimicrobial activity | |
| NO20060653L (no) | Isotiazolokinoloner og beslektede forbindelser som anti-infektive midler | |
| MY159560A (en) | Quinoline derivatives as antibacterial agents | |
| NO20065902L (no) | 3-{4-(pyridin-3-yl)fenyl}-5-(1H-,1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler | |
| NO20092655L (no) | 2-kinolinon- og 2-kinoksalinonderivater og deres anvendelse som antibakterielle midler | |
| EP2258372B8 (en) | A2A antagonists for use in the treatment of motor disorders | |
| NO20065889L (no) | 3-`4-{6-substituert alkanoyl)pyridin-3-yf}-3-fenyl!-5-(1 H-1,2,3-triazol-1-ylmetyl)-1,3-oksazolidin-2-oner som antibakterielle midler. | |
| MXPA05009688A (es) | Derivados de naftiridina como agentes antibacterianos. | |
| NO20080499L (no) | Kinolinderivater som antibakterielle midler | |
| NO20062629L (no) | Oksazolderivater av tetrackliner | |
| TW200740800A (en) | Oxazolidinone compounds, and compositions and methods related thereto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |